Regular use of aspirin can reduce cancer incidence, recurrence, metastasis and cancer-related mortality. Aspirin suppresses proliferation and induces apoptosis and autophagy in colorectal cancer cells, but the precise mechanism is not clear. In this study, we demonstrated that aspirin induced autophagosome formation in colorectal cancer cells, but autophagic degradation was blocked through aspirin-mediated Beclin 1 acetylation. Blocked autophagic degradation weakened aspirin-induced cell death. Collectively, our findings indicate the dual roles of aspirin on autophagy, and demonstrate a new mechanism by which Beclin 1 acetylation impairs the anticancer effect of aspirin in colorectal cancer cells.
CITATION STYLE
Sun, T., Ming, L., Yan, Y., Zhang, Y., & Xue, H. (2017). Beclin 1 acetylation impairs the anticancer effect of aspirin in colorectal cancer cells. Oncotarget, 8(43), 74781–74790. https://doi.org/10.18632/oncotarget.20367
Mendeley helps you to discover research relevant for your work.